130 related articles for article (PubMed ID: 19362965)
1. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
[TBL] [Abstract][Full Text] [Related]
2. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members.
Steingrímsdóttir H; Einarsdóttir HK; Haraldsdóttir V; Ogmundsdóttir HM
Eur J Haematol; 2011 May; 86(5):396-404. PubMed ID: 21342269
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
[TBL] [Abstract][Full Text] [Related]
4. Familial paraproteinemia: hyper-responsive B-cells as endophenotype.
Ögmundsdóttir HM; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):82-4. PubMed ID: 21454198
[TBL] [Abstract][Full Text] [Related]
5. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
10. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
11. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
12. A case-control and family study of Waldenstrom's macroglobulinemia.
Linet MS; Humphrey RL; Mehl ES; Brown LM; Pottern LM; Bias WB; McCaffrey L
Leukemia; 1993 Sep; 7(9):1363-9. PubMed ID: 8371587
[TBL] [Abstract][Full Text] [Related]
13. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families.
McMaster ML; Csako G; Giambarresi TR; Vasquez L; Berg M; Saddlemire S; Hulley B; Tucker MA
Clin Cancer Res; 2007 Sep; 13(17):5063-9. PubMed ID: 17785558
[TBL] [Abstract][Full Text] [Related]
15. The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.
Hatzimichael E; Dasoula A; Shah R; Syed N; Papoudou-Bai A; Coley HM; Dranitsaris G; Bourantas KL; Stebbing J; Crook T
Eur J Haematol; 2010 Jan; 84(1):47-51. PubMed ID: 19737309
[TBL] [Abstract][Full Text] [Related]
16. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
17. Familial Waldenstrom's macroglobulinemia.
McMaster ML
Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
[TBL] [Abstract][Full Text] [Related]
18. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.
Kuppusamy H; Ogmundsdottir HM; Baigorri E; Warkentin A; Steingrimsdottir H; Haraldsdottir V; Mant MJ; Mackey J; Johnston JB; Adamia S; Belch AR; Pilarski LM
PLoS One; 2014; 9(6):e100691. PubMed ID: 24950197
[TBL] [Abstract][Full Text] [Related]
19. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
Eurelings M; Lokhorst HM; Notermans NC; Krijtenburg PJ; Kessel Bv; Eleveld MJ; Bloem A; Wokke JH; Poot M; Buijs A
J Neurol Sci; 2007 Sep; 260(1-2):124-31. PubMed ID: 17543994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]